study
-
Spine
Karolinska Development’s portfolio company OssDsign completes patient enrollment to the TOP FUSION study
STOCKHOLM, SWEDEN, April 25, 2022. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company OssDsign has enrolled…
Read More » -
Spine
Spineart-100 U.S. Patients Treated In The Single Level IDE Clinical Trial Of BAGUERA®C Cervical Disc Prosthesis
LAGUNA HILLS, Calif., April 21, 2022 /PRNewswire/ — Spineart USA Inc. announced today that surgery has been performed on 100 patients in the single-level U.S.…
Read More » -
Biologics
Bone Therapeutics to strategically focus on lead cell therapy product ALLOB
REGULATED INFORMATION Strategic focus revised and fully focused on achieving topline results of the ALLOB Phase IIb study in tibial…
Read More » -
Spine
New Study Finds Surface Imaging Provides Highly Accurate Models of The Body for Scoliosis Surgeons
The technique, called 3dMD, uses an array of cameras to generate nearly instantaneous images of the torso, which can guide…
Read More » -
Spine
New EVoluSIon Study Data Demonstrates Strong Support for the SImmetry® Sacroiliac Joint Fusion System
Study published in the IJSS shows Surgalign product to be a reliable solution for SIJ dysfunction DEERFIELD, Ill., March 24,…
Read More » -
Recon
Study Finds Cementless Knee Replacement Outcomes Comparable to Standard Knee Implant, Less Time Needed in OR
CHICAGO, March 22, 2022 /PRNewswire/ — Cementless knee replacement, an alternative approach to traditional cemented knee replacement surgery, is garnering interest in the…
Read More » -
Spine
DiscGenics Announces Presentation of Positive Interim Clinical Data from Phase 1/2 Study of Cell Therapy for Degenerative Disc Disease
Allogeneic discogenic cell therapy was well tolerated and produced clinically meaningful, statistically significant improvements in low back pain, function, and…
Read More » -
Biologics
Cerapedics Completes Enrollment of Pivotal U.S. FDA IDE Study for its P-15L Bone Graft
The ASPIRE study is intended to evaluate the use of P-15L Bone Graft in transforaminal lumbar interbody fusion surgery in…
Read More » -
Recon
FX Solutions, SAS. [FX Shoulder, Inc.] Completes Easytech Reversed® Stemless IDE Enrollment in the USA
The First-and-Only Completed Stemless Reverse IDE in the USA DALLAS, Jan. 27, 2022 /PRNewswire/ — FX has completed the enrollment for their…
Read More » -
Recon
Hip Innovation Technology Receives FDA Investigational Device Exemption (IDE) Approval to Initiate Landmark Study of its Reverse Hip Replacement System
HIT’s Reverse Hip Replacement System may Revolutionize Total Hip Replacement Surgery BOCA RATON, Fla., Jan. 18, 2022 /PRNewswire/ — Hip Innovation Technology, LLC…
Read More » -
Hospitals
Merger Improved Quality and Safety at NYU Langone Hospital–Brooklyn
Results contrast other findings that most mergers do not improve quality or safety – even when they involve high-quality facilities…
Read More » -
Spine
New study finds procedures treating spinal fractures associated with reduction in opioid use and decreased payer costs
Study shows 57.1% of patients discontinued or reduced oral opioid prescription refills post-procedure and exhibited a decrease in payer costs¹…
Read More » -
Financial
Physician income declines when hospitals acquire practices, study shows
Those employed by health systems had about 49% lower Medicare billing, worked more hours per week and were in practice…
Read More » -
Recon
New HSS Study Finds Hip Replacements on the Rise Among Adolescents Under 21 Years of Age
NEW YORK, Nov. 9, 2021 /PRNewswire/ — A growing number of adolescents in the United States are undergoing total hip replacement surgeries, according to new…
Read More » -
Spine
Empirical Spine Presents Data from Study of the LimiFlex™ Tension Band at the Society for Minimally Invasive Spine Surgery (SMISS) Annual Forum 2021
Presentation highlights return to work, ADL, and disability improvement in 246 subjects with 12-month follow-up. SAN CARLOS, Calif., November 2,…
Read More »